Brandon Bolden

Running Back

Age: 30
Free Agency: 2022 (UFA)
Accrued Seasons: 8
  • 2020 Salary Cap Charge: $0 (0.00% of cap)
  • 2020 Cash Payout: $150,000 (0.10% of spending)
  • 2020 Cash to Cap Ratio: 0
  • Contract Value: $3,700,000 ($1,850,000 APY)
  • Fully Guaranteed Money: $2,000,000
  • Contract Ranking: 36/181 at RB

Current Contract

(UFA, signed 2019)
(📝: indicates contract trigger occuring during that year)
YearAgeBase SalaryProrated BonusPer Game Roster BonusGuaranteed SalaryCap
Number
Cap %
Dead Money & Cap Savings
201929$1,000,000$500,000$200,000$1,000,000$1,700,0000.9%
202030$0$0$0$0$00.0%
202131$1,300,000$500,000$200,000$0$1,987,5001.0%
Total$2,300,000$1,000,000$400,000$1,000,000$3,687,500

Contract Notes

Brandon Bolden signed a two year, $3.7 million contract with the Patriots on March 14, 2019. Bolden received a $1 million signing bonus and the total guarantee on the contract is $2 million. $400,000 of the deal is tied to per game bonuses. Another $1 million in incentives are available.Bolden opted out of the 2020 NFL season due to the Covid pandemic. His contract will now toll to 2021.
Career Earnings: $7,855,000
Career APY: $981,875
Potential Earnings: $9,225,000
Total Guarantees: $2,220,000
Largest Cash Payment: $2,187,500 (2019)
Largest Cap Number: $1,987,500 (2021)

Contract History

TeamContract TypeStatusYear SignedYrsTotalAPYGuaranteesAmount Earned% EarnedEffective APY
PatriotsUFATerminated20171$855,000$855,000$50,000$2,307,500269.9%$1,153,750
PatriotsSFAExpired20171$775,000$775,000$0$775,000100.0%$775,000
PatriotsUFATerminated20181$880,000$880,000$170,000$00.0%$0
DolphinsSFAExpired20181$850,000$850,000$0$850,000100.0%$850,000
PatriotsUFAActive20192$3,700,000$1,850,000$2,000,000$2,187,50059.1%$2,187,500
Earnings By Team
TeamYrsSalaryAPYPaid on Cap% Paid on CapPaid as Dead Money% Paid as Dead Money
Patriots7$7,005,000$1,000,714$6,076,2500.0%$280,0000.0%
Dolphins1$850,000$850,000$850,0000.0%$00.0%

Salary Cap History

YearTeamBase SalaryProrated BonusRoster BonusPer Game Roster BonusWorkout BonusGuaranteed SalaryCap
Number
Cap %Cash Paid
2012Patriots$390,000$4,584$0$0$0$0$394,5840.3%$405,000
2013Patriots$480,000$4,584$0$0$0$0$484,5840.4%$480,000
2014Patriots$570,000$4,582$0$0$0$0$574,5820.4%$570,000
2015Patriots$660,000$150,000$200,000$0$25,000$0$1,035,0000.7%$1,172,500
2016Patriots$760,000$150,000$350,000$0$25,000$0$1,272,5000.8%$1,135,000
2017Patriots$775,000$0$0$0$0$0$615,0000.4%$775,000
2018Dolphins$850,000$0$0$0$0$0$850,0000.5%$850,000
2019Patriots$1,000,000$500,000$0$200,000$0$1,000,000$1,700,0000.9%$2,187,500
2020Patriots$0$0$0$0$0$0$00.0%$150,000
2021Patriots$1,300,000$500,000$0$200,000$0$0$1,987,5001.0%$1,500,000
Total$6,785,000$1,313,750$550,000$400,000$50,000$1,000,000$8,913,750$9,225,000
Dead Money History
TeamYearCap ChargeCash Paid
Patriots2017$80,000$80,000
Patriots2018$200,000$200,000
Total$280,000$280,000

Statistics

YearGames PlayedGames MissedSnapsRushingReceivingFumbles
InjuredHealthyOffenseSpecialAttYardsAvgTDRecYardsAvgTDTotalLost
201210----7.9%33.8%562744.922115.5000
2013123122.5%31.1%552714.93211527.2000
201416006.4%61.2%28893.21284.0000
2015151017.2%53.4%632073.30191809.5200
201614201.2%58.9%144.002157.5000
201716003.7%60.0%4215.30000.0000
201816002.7%65.8%89111.423134.3111
201915108.3%70.8%15684.53911112.3100

Valuation Diamond

The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.

OTC ValuationAPY
Regular$0$0
Injury Adjusted$0$0
test
OTC Valuation $2.6M $5.2M $7.8M $10.4M $13.0M APY $2.7M $5.3M $8.0M $10.7M $13.3M $6,175,000 $5,150,000

Weekly Valuation Trends

The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.

To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.